NITRICIL
Dead / Abandoned — Abandoned — failure to respond (as of 15 Feb 2023)
What this means for you
This application is over — abandoned 01 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88536730
- Mark type
- Stylized text
- Filed
- 25 Jul 2019
- Published for opposition
- 05 Nov 2019
- Abandoned
- 01 Feb 2023
- Attorney of record
- Kathleen Lynch
Goods and services
- Class 005 — Pharmaceuticals: Nitric oxide releasing pharmaceutical preparations for use in dermatology and oncology and for the treatment of wounds and infectious disease
Owner
- Novan, Inc., Durham, NC, US
- Novan, Inc., Morrisville, NC, US
Prosecution history
- 16 Feb 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 15 Feb 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 15 Feb 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 31 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jul 2022 — NON-FINAL ACTION E-MAILED
- 31 Jul 2022 — SU - NON-FINAL ACTION - WRITTEN
- 23 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jun 2022 — USE AMENDMENT FILED
- 16 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 05 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jan 2022 — SOU EXTENSION 4 GRANTED
- 27 Dec 2021 — SOU EXTENSION 4 FILED
- 04 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED